Women in Pharma – Sukhada Chaturvedi Pharmapack 2023

This year at Pharmapack 2023, we interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in pharma. In the lead-up to International Women’s Day on March 8, 2023, CPHI Online is proud to highlight the women taking strides to make the industry a more inclusive and diverse workforce, and by extension an equal opportunity healthcare landscape.
We caught up with Sukhada Chaturvedi, International Account Manager at Körber, to discuss her journey through the pharmaceutical industry as a woman in STEM, and the challenges as well as strategies for creating an equal healthcare landscape.
Innovation requires diversity of gender and beyond
The female workforce, as Chaturvedi stated, faces more challenges than the male workforce in the pharmaceutical industry. Speaking from experience, Chaturvedi described having less opportunities available for women in the pharmaceutical workforce, especially in terms of divisions such as mechanics or sales. Female representation within the pharma industry should start at recruitment and the implementation of training to achieve and increase diversity within the team, she claimed.
Chaturvedi also extended the idea of diversity to other aspects of the human experience. Diversity of age, race, and background along with diversity of gender will naturally lead to a diversity of opinion – a necessary component for the pharmaceutical industry to innovate and push the future of healthcare forward. With women constituting 50% of the human population, Chaturvedi described how women bring forth 50% of new ideas and opinions to the pharmaceutical industry. “We bring more innovation, our experiences, our empath... Everything that we do in pharma is for the patients. The empathy part comes very naturally to women and I believe [bringing] that perspective would contribute a lot of changes in pharma,” Chaturvedi explained.
The future of pharma is female
“This should actually not be a topic of discussion because diversity should be the norm,” Chaturvedi proclaimed, but she remained aware that the pharmaceutical industry is still taking ‘baby steps’ to achieving true diversity and equality.
For women looking to start a career in pharmaceuticals or even for women currently working in one of the many pharmaceutical sectors, Chaturvedi encouraged all to set their sights on their goals: “I believe there is no stopping for women of any colour. Just take your passion with you, take everything else with a pinch of salt, and go for your goal.” She emphasised the importance of working together and in solidarity to strive towards individual goals – no one woman can do it alone.
She also encouraged everyone in the pharmaceutical industry, men and women of any department and position, to continue these discussions regarding gender equality. From female CEOs and managing directors to contractors to manufacturers, Chaturvedi believes that the pharma industry is still taking baby steps towards the big leap, part of which will be continuing the discussion: “I believe in the future, we will have [total gender equality] as a norm.”
Related News
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Women in Pharma: Manufacturing personal and team success
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience. -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Trump administration halts global supply of HIV, malaria, tuberculosis drugs
In various memos circulated to the United States Agency for International Development (USAID), the Trump administration has demanded contractors and partners to immediately stop work in supplying lifesaving drugs for HIV, malaria, and tuberculosis to c... -
News 2024 Drug Approvals: a lexicon of notable drugs and clinical trials
50 drugs received FDA approval in 2024. The centre for biologics evaluation and research also identified six new Orphan drug approvals as under Biologics License Applications (BLAs). The following list picks out key approvals from the list, and highlig...
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance